Eli Lilly and Company

Top Publications

Top Publications Authored or Co-Authored in "Eli Lilly and Company"

• Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study

  JAMA Oncology, Volume 5, No. 12, Year 2019, Citations 1593
• Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

  The Lancet, Volume 394, No. 10193, Year 2019, Citations 1505
• Mapping genomic loci implicates genes and synaptic biology in schizophrenia

  Nature, Volume 604, No. 7906, Year 2022, Citations 842
• Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

  New England Journal of Medicine, Volume 367, No. 14, Year 2012, Citations 459
• Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

  The Lancet Diabetes and Endocrinology, Volume 6, No. 8, Year 2018, Citations 401